Overview

A Study to Compare Safety and Efficacy of OPT-80(Fidaxomicin) With Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea (CDAD)

Status:
Completed

Trial end date:
2016-09-08

Target enrollment:

Participant gender:

Summary

The primary objective of this study is to investigate the safety and efficacy of OPT-80 versus vancomycin in subjects with Clostridium difficile-associated diarrhea (CDAD).

Phase:

Phase 3

Details

Lead Sponsor:

Astellas Pharma Inc

Treatments:

Fidaxomicin
Vancomycin